Robert E. Cohen
55Patents
10h-index
75Co-inventors
81Inventor score
Filing activity: May 30, 1978 → Apr 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4264750A | Process for fluorinating polymers | Performing Operations; Transporting | 54 | Expired |
| US4216743A | Magnetically unlocked pet door | Fixed Constructions | 49 | Expired |
| US7455835B2 | Methods for treating immune system diseases using a soluble CTLA4 molecule | Chemistry; Metallurgy | 43 | Expired |
| US8313798B2 | Structural colors having UV reflectance via spray layer-by-layer processing | Physics | 43 | Active |
| US4404256A | Surface fluorinated polymers | Emerging Cross-Sectional Technologies | 42 | Expired |
| US6221447A | Rubber products that shrink due to the application of energy and hypo-allergenic rubbery products | Emerging Cross-Sectional Technologies | 31 | Expired |
| US4593050A | Ultraviolet light assisted fluorination of polymer surfaces | Emerging Cross-Sectional Technologies | 21 | Expired |
| US8446666B2 | UV-reflective structural color | Chemistry; Metallurgy | 19 | Active |
| US8986848B2 | Coatings | Emerging Cross-Sectional Technologies | 14 | Active |
| US8497247B2 | Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 11 | Active |
| US8153233B2 | Patterned coatings having extreme wetting properties and methods of making | Emerging Cross-Sectional Technologies | 9 | Active |
| US8227420B2 | Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID | Chemistry; Metallurgy | 9 | Active |
| US6946172B2 | Rubbery products that shrink due to the application of energy and hypo-allergic rubbery products | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8148332B2 | Method for treating a rheumatic disease using a soluble TLA4 molecule | Chemistry; Metallurgy | 8 | Active |
| US7904146B2 | Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions | Human Necessities | 8 | Active |
| US7842352B2 | Nanoparticle coatings and methods of making | Physics | 8 | Active |
| US8722632B2 | Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 7 | Active |
| US7251893B2 | Tribological applications of polyelectrolyte multilayers | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8709582B2 | Optical article including an antireflecting coating having antifog properties and process for making same | Emerging Cross-Sectional Technologies | 6 | Active |
| US9296808B2 | Methods for treating scleroderma by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 5 | Active |
| US8703718B2 | Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule | Chemistry; Metallurgy | 5 | Active |
| US9506846B2 | High definition nanomaterials | Physics | 5 | Active |
| US4608309A | Thermal energy storage slurry material | Emerging Cross-Sectional Technologies | 5 | Expired |
| US9650518B2 | Liquid repellent surfaces | Chemistry; Metallurgy | 5 | Active |
| US4167544A | Polymer blends | Emerging Cross-Sectional Technologies | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.